This company listing is no longer active
TEHP Stock Overview
Operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Avid Bioservices, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.10 |
| 52 Week High | US$12.10 |
| 52 Week Low | US$5.35 |
| Beta | 1.39 |
| 1 Month Change | 0.83% |
| 3 Month Change | 22.22% |
| 1 Year Change | 108.62% |
| 3 Year Change | -31.64% |
| 5 Year Change | 110.43% |
| Change since IPO | -75.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| TEHP | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 1.7% | 0.2% | 0.9% |
| 1Y | 108.6% | -11.8% | 13.2% |
Return vs Industry: TEHP exceeded the German Biotechs industry which returned -3.9% over the past year.
Return vs Market: TEHP exceeded the German Market which returned 13.3% over the past year.
Price Volatility
| TEHP volatility | |
|---|---|
| TEHP Average Weekly Movement | 4.1% |
| Biotechs Industry Average Movement | 5.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: TEHP has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: TEHP's weekly volatility has decreased from 9% to 4% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 371 | Nick Green | www.avidbio.com |
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018.
Avid Bioservices, Inc. Fundamentals Summary
| TEHP fundamental statistics | |
|---|---|
| Market cap | €768.65m |
| Earnings (TTM) | -€146.41m |
| Revenue (TTM) | €144.86m |
5.3x
P/S Ratio-5.3x
P/E RatioIs TEHP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TEHP income statement (TTM) | |
|---|---|
| Revenue | US$150.45m |
| Cost of Revenue | US$138.89m |
| Gross Profit | US$11.55m |
| Other Expenses | US$163.60m |
| Earnings | -US$152.05m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.38 |
| Gross Margin | 7.68% |
| Net Profit Margin | -101.07% |
| Debt/Equity Ratio | 344.0% |
How did TEHP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/04 22:13 |
| End of Day Share Price | 2025/02/04 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avid Bioservices, Inc. is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Charles Duncan | Citizens JMP Securities, LLC |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Vernon Bernardino | FBR Capital Markets & Co. |